Products from Innaxon
Innaxon is a company based in Tewkesbury, United Kingdom focussing on innate immunity, Toll-like Receptor (TLR) agonists and small molecule inhibitors. Innaxon develops and manufactures defined “Immunoceuticals” of the highest activity and purity for pre-clinical research and development applications for vaccine adjuvants and immunotherapy. Their unique biological and synthetic TLR ligands are well-characterized and effective biological response modifiers of inappropriate or disproportionate immune responses.
More information at: www.adipogen.com/innaxon
No results were found for the filter!
Lipid A from E. coli R515 (Re) TLRpure Sterile Solution
Item number: IAX-100-004-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.1-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly...
| Keywords: | Lipid A derived from E. coli R515 (Re) LPS (biosynthetic) |
| Application: | TLR4 activator |
From 156.00€
*
LPS from S. minnesota R7 (Rd1) TLRpure Sterile Solution
Item number: IAX-100-018-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.05-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from S. minnesota strain R7 (Rd1), R-type (rough/mutant) LPS |
| Application: | TLR4 activator |
From 175.00€
*
LPS from S. enteritidis (S-form) TLRpure Sterile Solution
Item number: IAX-100-019-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from Salmonella enteritidis, S-type (smooth/wild-type) LPS |
| Application: | TLR4 activator |
From 206.00€
*
LPS from S. minnesota (S-form) TLRpure Sterile Solution
Item number: IAX-100-020-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from Salmonella minnesota, S-type (smooth/wild-type) LPS |
| Application: | TLR4 activator |
From 175.00€
*
ODN 2216 (Type A) Endotoxin-free (sterile)
Item number: IAX-200-005-C100
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 6644 D |
From 218.00€
*
LPS from E. coli O8:K27 (S-form) TLRpure Sterile Solution
Item number: IAX-100-006-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from E. coli O8:K27, S-type (smooth/wild-type) LPS |
| Application: | TLR4 activator |
From 157.00€
*
LPS from E. coli R515 (Re) TLRpure Sterile Solution
Item number: IAX-100-007-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.05-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from E. coli strain R515 (Re), R-type (rough/mutant) LPS |
| Application: | TLR4 activator |
From 175.00€
*
LPS from S. minnesota R595 (Re) TLRpure Sterile Solution
Item number: IAX-100-008-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.05-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from S. minnesota strain R595 (Re), R-type (rough/mutant) LPS |
| Application: | TLR4 activator |
From 175.00€
*
LPS from E. coli J5 (Rc) TLRpure Sterile Solution
Item number: IAX-100-014-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.05-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from E. coli strain J5 (Rc), R-type (rough/mutant) LPS |
| Application: | TLR4 activator |
From 175.00€
*
LPS from S. minnesota R345 (Rb) TLRpure Sterile Solution
Item number: IAX-100-015-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.05-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
| Keywords: | Lipopolysaccharide (LPS) from S. minnesota strain R345 (Rb), R-type (rough/mutant) LPS |
| Application: | TLR4 activator |
From 175.00€
*
ODN 1585 (Type A) Endotoxin-free (sterile)
Item number: IAX-200-003-C100
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2218 (Cat. No.: IAX-200-203). Unmethylated CG dinucleotides within particular sequence contexts are...
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: rodent) |
| Application: | TLR9 activator |
| MW: | 6643 D |
From 218.00€
*
iODN (inhibitory ODN) 2088 Endotoxin-free (sterile)
Item number: IAX-200-050-3001
3 x 1 mg. Potent sequence of an inhibitory ODN for in vivo use in rodents (50-150 µg per injection): prototype class I, may also affect TLR7 and TLR8 signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 4887 D |
From 179.00€
*